Wegovy Pill Just Changed: Why Lilly Stock Could Still Win
A new oral Wegovy launch is reshaping GLP-1 dynamics. Even with Novo Nordisk gaining ground, Eli Lilly stock could st...
Learn which low fee index funds beat the market in 2024 and how they can fit into a retirement strategy. This guide highlights top performers and practical steps for investors.
28,527 articlesA new oral Wegovy launch is reshaping GLP-1 dynamics. Even with Novo Nordisk gaining ground, Eli Lilly stock could st...
Stellantis unveiled a bold €60 billion turnaround plan at Investor Day, aiming to reshape costs, cash flow, and a mod...
U.S. markets wobbled as Opendoor dropped on margin concerns while housing demand hints kept some optimism alive. This...
Today’s trading session spotlighted PayPal as takeover rumors circulated, lifting the stock while the broader market ...
Hyperliquid (HYPE) enters the top 10 by market cap, surpassing Dogecoin and signaling a rare DeFi-led move in a chopp...
CryptoQuant data shows the altcoin market reaches extreme weakness, with 40% of tokens trading near all-time lows as ...
Howard Hanna NYC launches a major hiring spree, adding 26 agents to its Manhattan operation. The move includes the An...
We examine how wealthy buyers are sustaining housing activity even as the broader market cools for most households. T...
The SEC's updated listing standards could cut the time to a Cardano spot ETF dramatically, using CME Group's Cardano ...
A broad market rally lifted major indexes on Feb. 24 as traders anticipated Nvidia’s earnings and awaited remarks fro...
Anthropic’s looming IPO could reshape AI investing. With a private valuation near the hundreds of billions and big te...
The July Fourth week masked the broader strength in local housing markets. National data showed seasonal lull, but th...